CLINICAL_TRIALS
trial_result
· 2014-07-08
Clinical Trial Update: A Study of Avastin (Bevacizumab) in Patients With Multiple Myeloma [Phase 2]
Summary
A Phase 2 study of Avastin (bevacizumab) in patients with multiple myeloma has been terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2014-07-08